Latest filing published 05 Feb 2019 for Aclaris Therapeutics, Inc..
Insider track record
Christopher Powala: trading record in brief
Christopher Powala discloses dealings in Aclaris Therapeutics, Inc. to SEC (Form 4). The record holds 14 filings, for trades running from 18 December 2016 to 1 February 2019.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 5 February 2019 with an option exercise in Aclaris Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher Powala
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,400 sharesCommon StockSEC:0001209191-19-007489:0
- 1,114 shares@ US$6.9619.9% of flowCommon StockSEC:0001209191-19-007489:1
- 446 shares@ US$6.307.3% of flowCommon StockSEC:0001209191-18-063801:1
- 1,625 sharesCommon StockSEC:0001209191-18-063801:0
- 357 shares@ US$7.316.8% of flowCommon StockSEC:0001209191-18-063368:1
- 1,300 sharesCommon StockSEC:0001209191-18-063368:0
- 5,200 sharesCommon StockSEC:0001209191-18-028859:0
- 1,480 shares@ US$18.1033.5% of flowCommon StockSEC:0001209191-18-028859:1
- 1,300 sharesCommon StockSEC:0001209191-17-066819:0
- 1,625 sharesCommon StockSEC:0001209191-17-066819:2
- 395 shares@ US$24.2312.1% of flowCommon StockSEC:0001209191-17-066819:1
- 494 shares@ US$24.1215.1% of flowCommon StockSEC:0001209191-17-066819:3
- 1,625 sharesCommon StockSEC:0001209191-16-156178:0
- 494 shares@ US$31.2522.1% of flowCommon StockSEC:0001209191-16-156178:1
14 of 14 declarations
